234 related articles for article (PubMed ID: 23228009)
21. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
Tong ZY; Toshiaki Y; Wang YJ
Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
[TBL] [Abstract][Full Text] [Related]
22. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study.
Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S
Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705
[TBL] [Abstract][Full Text] [Related]
23. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
Auer DP; Wilke M; Grabner A; Heidenreich JO; Bronisch T; Wetter TC
Schizophr Res; 2001 Oct; 52(1-2):87-99. PubMed ID: 11595395
[TBL] [Abstract][Full Text] [Related]
24. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.
Bertolino A; Nawroz S; Mattay VS; Barnett AS; Duyn JH; Moonen CT; Frank JA; Tedeschi G; Weinberger DR
Am J Psychiatry; 1996 Dec; 153(12):1554-63. PubMed ID: 8942451
[TBL] [Abstract][Full Text] [Related]
25. N-acetyl-aspartate levels correlate with intra-axonal compartment parameters from diffusion MRI.
Grossman EJ; Kirov II; Gonen O; Novikov DS; Davitz MS; Lui YW; Grossman RI; Inglese M; Fieremans E
Neuroimage; 2015 Sep; 118():334-43. PubMed ID: 26037050
[TBL] [Abstract][Full Text] [Related]
26. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
27. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.
Lim KO; Adalsteinsson E; Spielman D; Sullivan EV; Rosenbloom MJ; Pfefferbaum A
Arch Gen Psychiatry; 1998 Apr; 55(4):346-52. PubMed ID: 9554430
[TBL] [Abstract][Full Text] [Related]
28. Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
Tedeschi G; Litvan I; Bonavita S; Bertolino A; Lundbom N; Patronas NJ; Hallett M
Brain; 1997 Sep; 120 ( Pt 9)():1541-52. PubMed ID: 9313638
[TBL] [Abstract][Full Text] [Related]
29. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.
Bertolino A; Callicott JH; Elman I; Mattay VS; Tedeschi G; Frank JA; Breier A; Weinberger DR
Biol Psychiatry; 1998 May; 43(9):641-8. PubMed ID: 9582997
[TBL] [Abstract][Full Text] [Related]
30. Reproducibility and reliability of short-TE whole-brain MR spectroscopic imaging of human brain at 3T.
Ding XQ; Maudsley AA; Sabati M; Sheriff S; Dellani PR; Lanfermann H
Magn Reson Med; 2015 Mar; 73(3):921-8. PubMed ID: 24677384
[TBL] [Abstract][Full Text] [Related]
31. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
[TBL] [Abstract][Full Text] [Related]
32. In vivo quantitative proton MRSI study of brain development from childhood to adolescence.
Horská A; Kaufmann WE; Brant LJ; Naidu S; Harris JC; Barker PB
J Magn Reson Imaging; 2002 Feb; 15(2):137-43. PubMed ID: 11836768
[TBL] [Abstract][Full Text] [Related]
33. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
[TBL] [Abstract][Full Text] [Related]
34. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
35. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
[TBL] [Abstract][Full Text] [Related]
36. Multisection proton MR spectroscopy for mesial temporal lobe epilepsy.
Capizzano AA; Vermathen P; Laxer KD; Matson GB; Maudsley AA; Soher BJ; Schuff NW; Weiner MW
AJNR Am J Neuroradiol; 2002 Sep; 23(8):1359-68. PubMed ID: 12223379
[TBL] [Abstract][Full Text] [Related]
37. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.
Suhy J; Miller RG; Rule R; Schuff N; Licht J; Dronsky V; Gelinas D; Maudsley AA; Weiner MW
Neurology; 2002 Mar; 58(5):773-9. PubMed ID: 11889242
[TBL] [Abstract][Full Text] [Related]
38. Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia.
Camicioli RM; Korzan JR; Foster SL; Fisher NJ; Emery DJ; Bastos AC; Hanstock CC
Neurosci Lett; 2004 Jan; 354(3):177-80. PubMed ID: 14700725
[TBL] [Abstract][Full Text] [Related]
39. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
40. Multi-voxel magnetic resonance spectroscopy of cerebral metabolites in healthy dogs at 1.5 Tesla.
Choi S; Song Y; Lee K; Lee Y; Choi H
J Vet Sci; 2016 Jun; 17(2):217-24. PubMed ID: 26645339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
